Comments

Medifast Stock Guidance

MEDNYSE

Logo brought to you by Benzinga Data

Trade with Public

$12.03

0.030.25%

At close: Dec 16, 4:00 PM EST

$12.03

N/A

After Hours: 4:00 PM EST

Overview News Earnings Options

Guidance

Dividends Analyst Ratings Insider Trades Short Interest Stock Report

Medifast Stock Guidance | NYSE:MED | Benzinga

Medifast issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/03/2025	MED	Medifast	Q4	2025	-$1.25	-$0.70	-$0.22	$65.00M	$80.00M	$88.17M	Get Alert
08/04/2025	MED	Medifast	Q3	2025	-$0.60	$0.00	-$0.19	$70.00M	$90.00M	$99.14M	Get Alert
04/28/2025	MED	Medifast	Q2	2025	-$0.55	$0.00	-$0.07	$85.00M	$105.00M	$112.30M	Get Alert
02/18/2025	MED	Medifast	Q1	2025	-$0.50	$0.00	-$0.19	$100.00M	$120.00M	$130.75M	Get Alert
11/04/2024	MED	Medifast	Q4	2024	$0.10	$0.65	-$0.18	$100.00M	$120.00M	$129.95M	Get Alert
08/05/2024	MED	Medifast	Q3	2024	-$0.70	-$0.05	-$0.52	$125.00M	$145.00M	$161.80M	Get Alert
04/29/2024	MED	Medifast	Q2	2024	$0.05	$0.40	$0.78	$150.00M	$170.00M	$168.90M	Get Alert
02/20/2024	MED	Medifast	Q1	2024	$0.25	$0.95	$1.49	$155.00M	$175.00M	$205.79M	Get Alert
11/06/2023	MED	Medifast	FY	2023	$8.65	$9.55	$8.52	$1.05B	$1.07B	$1.09B	Get Alert
08/07/2023	MED	Medifast	Q3	2023	$0.71	$1.32	$1.43	$220.00M	$240.00M	$269.57M	Get Alert
05/01/2023	MED	Medifast	Q2	2023	$1.32	$1.44	$2.82	$250.00M	$270.00M	$313.16M	Get Alert
02/21/2023	MED	Medifast	Q1	2023	$1.75	$2.40	$3.26	$300.00M	$320.00M	$374.30M	Get Alert
11/03/2022	MED	Medifast	FY	2022	$11.61	$13.05	$12.28	$1.51B	$1.59B	$1.60B	Get Alert
08/03/2022	MED	Medifast	FY	2022	$12.70	$14.10	$15.38	$1.58B	$1.66B	$1.81B	Get Alert
05/02/2022	MED	Medifast	FY	2022	$14.60	$16.05	$15.62	$1.78B	$1.84B	$1.77B	Get Alert
02/23/2022	MED	Medifast	FY	2022	$14.50	$16.00	$15.96	$1.72B	$1.79B	$1.74B	Get Alert

FAQ

What is the most recent guidance for Medifast (MED)?

The most recent guidance for Medifast (MED) was reported on November 3, 2025 for Q4 2025. The company provided earnings per share guidance in the range of $-1.25 to $-0.70, compared to the estimated EPS of $-0.22. Additionally, Medifast forecasted revenue between $0.07B and $0.08B for the quarter.

Browse guidance and forecast on all stocks.